Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension

Next Previous
Search
Trial Profile

An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bimatoprost (Primary) ; Bimatoprost; Latanoprost; Timolol
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus First in man; Therapeutic Use
  • Acronyms APOLLO
  • Sponsors Allergan

    • Most Recent Events

    • 28 May 2022 Results of a pooled analysis of data from 2 phase III studies and one phase I/II study (NCT02247804, NCT02250651, and NCT01157364) assessed the single administration of intracameral Bimatoprost implant 10 µg in patients with Open-Angle Glaucoma or Ocular Hypertension, published in the Ophthalmology and Therapy
    • 25 Feb 2020 According to an Allergan media release, data from this study will be presented at the Annual Meeting of the American Glaucoma Society (AGS).
    • 28 Dec 2019 Results published in the Drugs

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top